Genetic Imaging of Neuroinflammation in Parkinson’s Disease: Recent Advancements

Genetic Imaging of Neuroinflammation in Parkinson’s Disease: Recent Advancements

Parkinson’s disease (PD) is one of the most prevalent neurodegenerative aging disorders characterized by motor and non-motor symptoms due to the selective loss of midbrain dopaminergic (DA) neurons. The decreased viability of DA neurons slowly results in the appearance of motor symptoms such as rigi...

Full description

Bibliographic Details
Main Authors:	Longping Yao, Jiayu Wu, Sumeyye Koc, Guohui Lu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	Parkinson’s disease microglia genetics neuroinflamamation dopaminergic neurons neurotoxins
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2021.655819/full

Similar Items

Microglia Specific Drug Targeting Using Natural Products for the Regulation of Redox Imbalance in Neurodegeneration
by: Shashank Kumar Maurya, et al.
Published: (2021-04-01)

Comprehensive Analysis of Neurotoxin-Induced Ablation of Dopaminergic Neurons in Zebrafish Larvae
by: Michael Kalyn, et al.
Published: (2019-12-01)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
by: Siyan Zhang, et al.
Published: (2020-08-01)

Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures
by: Yan Zhu, et al.
Published: (2015-12-01)

Behavioral alterations in models of Parkinson's disease
by: Tillerson, Jennifer Layne
Published: (2008)

Studying the Pathophysiology of Parkinson’s Disease Using Zebrafish
by: Lisa M. Barnhill, et al.
Published: (2020-07-01)

Roles of stem cells in the treatment of Parkinson's disease
by: Yasaman Ebrahimikia, et al.
Published: (2018-10-01)

Mechanisms of Dopaminergic Neurodegeneration in Parkinson's Disease
by: Verma, Aditi
Published: (2018)

Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration
by: Itzia Jimenez-Ferrer, et al.
Published: (2017-10-01)

Animal Models of Autosomal Recessive Parkinsonism
by: Guendalina Bastioli, et al.
Published: (2021-07-01)

Glial cells in intracerebral transplantation for Parkinson’s disease
by: Nikola Tomov
Published: (2020-01-01)

Parkinson’s disease: general features, effects of levodopa treatment and future directions
by: Marco Aurelio M Freire, et al.
Published: (2010-11-01)

Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson’s Disease through Activating Mitophagy
by: Ming-Wei Lin, et al.
Published: (2019-12-01)

Brain‐derived neurotrophic factor attenuates cognitive impairment and motor deficits in a mouse model of Parkinson's disease
by: E Chang, et al.
Published: (2021-08-01)

The Interplay Between Beta-Amyloid 1–42 (Aβ1–42)-Induced Hippocampal Inflammatory Response, p-tau, Vascular Pathology, and Their Synergistic Contributions to Neuronal Death and Behavioral Deficits
by: Beatriz Calvo-Flores Guzmán, et al.
Published: (2020-11-01)

Altered expression patterns of inflammation-associated and trophic molecules in substantia nigra and striatum brain samples from Parkinson’s disease, incidental Lewy body disease and normal control cases
by: Douglas Gordon Walker, et al.
Published: (2016-01-01)

Understanding miRNA Based Gene Regulation in Parkinson’s Disease: An in silico Approach
by: Surya Narayan Rath, et al.
Published: (2020-03-01)

Kaempferol alleviates LD-mitochondrial damage by promoting autophagy: Implications in Parkinson's disease
by: Xiaojuan Han, et al.
Published: (2021-05-01)

Neuron-Astrocyte Interactions in Parkinson’s Disease
by: Ikuko Miyazaki, et al.
Published: (2020-12-01)

Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson’s disease.
by: Marta Raquel Carrola Esteves, et al.
Published: (2015-03-01)

Aromatic-Turmerone Analogs Protect Dopaminergic Neurons in Midbrain Slice Cultures through Their Neuroprotective Activities
by: Yuria Hori, et al.
Published: (2021-05-01)

Genetic inactivation of alpha-synuclein affects embryonic development of dopaminergic neurons of the substantia nigra, but not the ventral tegmental area, in mouse brain
by: Tatiana V. Tarasova, et al.
Published: (2018-05-01)

Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson's disease
by: Venissa Machado, et al.
Published: (2016-04-01)

Combining Gene Transfer and Nonhuman Primates to Better Understand and Treat Parkinson’s Disease
by: Christelle Lasbleiz, et al.
Published: (2019-02-01)

Mesenchymal stem cells that located in the electromagnetic fields improves rat model of Parkinson's disease
by: Majid Jadidi, et al.
Published: (2016-07-01)

Connectivity and Functionality of the Globus Pallidus Externa Under Normal Conditions and Parkinson's Disease
by: Jie Dong, et al.
Published: (2021-03-01)

Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease
by: Madiha Rasheed, et al.
Published: (2021-05-01)

Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson’s disease
by: Julian L. Goggi, et al.
Published: (2020-08-01)

Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson’s disease animal model
by: Atsushi Fujita, et al.
Published: (2018-08-01)

Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood–brain barrier, and damage in the nigral dopaminergic system
by: Mayka Tomás-Camardiel, et al.
Published: (2004-06-01)

Conditioned Medium Protects Dopaminergic Neurons in Parkinsonian Rats
by: Malihe Nakhaeifard, et al.
Published: (2018-06-01)

Do we need to redefine the advanced stage in Parkinson’s disease?
by: Ángel Sesar, et al.
Published: (2021-10-01)

Roles of FGF20 in dopaminergic neurons and Parkinson’s disease
by: Nobuyuki eItoh, et al.
Published: (2013-05-01)

Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson’s Disease?
by: Gaia Faustini, et al.
Published: (2017-12-01)

Degeneration of dopaminergic neurons due to metabolic alterations and Parkinson’s disease
by: Juhyun eSong, et al.
Published: (2016-03-01)

GDNF signaling in subjects with minimal motor deficits and Parkinson's disease
by: Yaping Chu, et al.
Published: (2021-06-01)

Vulnerable Parkin Loss-of-Function Drosophila Dopaminergic Neurons Have Advanced Mitochondrial Aging, Mitochondrial Network Loss and Transiently Reduced Autophagosome Recruitment
by: Juliana Cackovic, et al.
Published: (2018-02-01)

Differential effect of Ayurvedic nootropics on C. elegans models of Parkinson’s disease
by: Jalagam Anjaneyulu, et al.
Published: (2020-10-01)

HOME-BASED AEROBIC EXERCISE AMELIORATES SYMPTOMS IN PATIENTS WITH PARKINSONS DISEASE
by: Yoichi Ohno
Published: (2018-02-01)

The Promise of the Zebrafish Model for Parkinson’s Disease: Today’s Science and Tomorrow’s Treatment
by: Khairiah Razali, et al.
Published: (2021-04-01)